We are live on
!
Find out more
FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$434M
1-Year Est. Return
9.09%
This Fund
S&P 500
This Quarter
Est. Return
-10.8%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$538M
AUM Growth
-$127M
(-19%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-29.76%
Top 10 Holdings %
Top 10 Hldgs %
40.16%
Holding
76
New
5
Increased
12
Reduced
42
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$9.41M |
| 2 |
Union Pacific
UNP
|
+$9.03M |
| 3 |
Chevron
CVX
|
+$3.59M |
| 4 |
Oracle
ORCL
|
+$3.49M |
| 5 |
Mattel
MAT
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$24.2M |
| 2 |
Baxter International
BAX
|
+$13.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$11.9M |
| 4 |
Norfolk Southern
NSC
|
+$10.8M |
| 5 |
APA Corp
APA
|
+$7.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.79% |
| 4 | Industrials | 8.61% |
| 5 | Materials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$35.1B
| $31.2M | 5.81% |
466,215
-183,986
| -28% | -$11.9M |
|
2
Medtronic
MDT
$105B
| $30.1M | 5.59% |
395,802
-71,259
| -15% | -$5.25M |
|
3
Microsoft
MSFT
$2.9T
| $24.1M | 4.47% |
428,767
-136,826
| -24% | -$6.14M |
|
4
Verizon
VZ
$185B
| $21.9M | 4.08% |
422,917
-83,967
| -17% | -$3.87M |
|
5
PNC Financial Services
PNC
$101B
| $21.7M | 4.03% |
206,926
-59,894
| -22% | -$5.63M |
|
|
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
| $19.4M | 3.6% |
188,343
-78,238
| -29% | -$7.07M |
|
7
MetLife
MET
$60B
| $19.1M | 3.55% |
357,420
-113,082
| -24% | -$5.28M |
|
8
Johnson & Johnson
JNJ
$615B
| $17.2M | 3.2% |
149,684
-26,626
| -15% | -$2.58M |
|
9
Pfizer
PFE
$141B
| $15.8M | 2.93% |
452,087
-112,415
| -20% | -$3.6M |
|
10
Avnet
AVT
$7.39B
| $15.6M | 2.9% |
289,239
-68,004
| -19% | -$2.83M |
|
11
Johnson Controls International
JCI
$86.9B
| $15.2M | 2.83% |
288,714
-43,544
| -13% | -$2.01M |
|
12
Bunge Global
BG
$24B
| $14.9M | 2.77% |
157,888
-55,515
| -26% | -$4.3M |
|
13
State Street
STT
$50.9B
| $13.3M | 2.48% |
157,068
-53,042
| -25% | -$3.95M |
|
14
Check Point Software Technologies
CHKP
$13.3B
| $13M | 2.42% |
115,174
-63,908
| -36% | -$5.11M |
|
|
15
Mattel
MAT
$4.18B
| $13M | 2.41% |
615,172
+64,550
| +12% | +$1.51M |
|
|
16
Baxter International
BAX
$11.2B
| $12.2M | 2.28% |
305,057
-350,545
| -53% | -$13.3M |
|
|
PPL
17
PPL Corp
PPL
$27.2B
| $12.1M | 2.24% |
291,073
-90,444
| -24% | -$2.83M |
|
18
The Mosaic Company
MOS
$7.24B
| $11.7M | 2.18% |
294,373
-102,799
| -26% | -$4.24M |
|
|
TUP
19
DELISTED
Tupperware Brands Corporation
TUP
| $11.2M | 2.09% |
168,854
-6,492
| -4% | -$364K |
|
20
ICL Group
ICL
$6.87B
| $10.3M | 1.91% |
1,373,876
-574,777
| -29% | -$3.6M |
|
21
Reinsurance Group of America
RGA
$15.4B
| $9.69M | 1.8% |
73,822
-50,975
| -41% | -$4.79M |
|
|
22
Oracle
ORCL
$362B
| $9.51M | 1.77% |
197,186
+90,847
| +85% | +$3.49M |
|
|
23
Union Pacific
UNP
$174B
| $8.75M | 1.63% |
+99,000
| New | +$9.03M |
|
24
CSX Corp
CSX
$92.8B
| $8.65M | 1.61% |
642,135
-254,724
| -28% | -$2.5M |
|
|
BXLT
25
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $8.59M | 1.6% |
+272,717
| New | +$9.41M |
|
Similar funds
HCM
GS
IA
WCM
PAMS
SSWG
JWM
GDS
Foyston, Gordon, & Payne's Q3 2015 Portfolio in Review
As of Q3 2015, Foyston, Gordon, & Payne held 76 positions worth $538M, down 19% from $665M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $160M in Q3 2015, closing 5 positions and reducing 42 holdings. Its most notable exit was Norfolk Southern, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
Against the trend, Foyston, Gordon, & Payne opened a new position in BAXALTA INC COM STK (DE) worth $8.59M.
- Foyston, Gordon, & Payne's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 272,717 shares worth $8.59M.
- Foyston, Gordon, & Payne added most to Oracle in Q3 2015, an estimated $3.49M increase.
- Foyston, Gordon, & Payne's biggest Q3 2015 reduction was Conagra Brands, cutting an estimated $24.2M.
- Foyston, Gordon, & Payne fully exited Norfolk Southern in Q3 2015, selling an estimated $10.8M.
- Foyston, Gordon, & Payne's ten largest holdings make up 40% of its $538M portfolio in Q3 2015.
- Foyston, Gordon, & Payne opened 5 new positions and closed 5 in Q3 2015.
- Foyston, Gordon, & Payne's portfolio value fell 19% quarter-over-quarter to $538M.
Based on Foyston, Gordon, & Payne's 13F filing for Q3 2015, filed 13 Nov 2015.